Medipower -M (MDPR) — Net Asset Quality Index
Medipower -M (MDPR) has a Net Asset Quality Index of 34.2% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ILA460.05 Million minus total liabilities of ILA302.52 Million yields net assets of ILA157.53 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Medipower -M defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Medipower -M Net Asset Quality Index Over Time (2006–2024)
This chart shows how Medipower -M's Net Asset Quality Index has evolved across 19 annual periods from 2006 to 2024. As of September 2025, the index stands at 34.2%, representing net assets of ILA157.53 Million against total assets of ILA460.05 Million ILA. Explore how efficiently does Medipower -M generate cash to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Medipower -M (2006–2024)
The table below presents the year-by-year Net Asset Quality Index for Medipower -M from 2006 to 2024, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market value of Medipower -M.
| Year | Quality Index | Net Assets (ILA) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 36.4% | ILA151.53 Million | ILA416.43 Million | ILA264.89 Million | ▲ +2.5 pp |
| 2023 | 33.9% | ILA141.36 Million | ILA416.57 Million | ILA275.21 Million | ▲ +2.5 pp |
| 2022 | 31.4% | ILA132.20 Million | ILA420.70 Million | ILA288.49 Million | ▲ +3.8 pp |
| 2021 | 27.6% | ILA111.22 Million | ILA403.02 Million | ILA291.80 Million | ▼ -2.9 pp |
| 2020 | 30.5% | ILA80.93 Million | ILA265.25 Million | ILA184.33 Million | ▼ -5.3 pp |
| 2019 | 35.8% | ILA78.17 Million | ILA218.59 Million | ILA140.42 Million | ▼ -3.5 pp |
| 2018 | 39.2% | ILA75.40 Million | ILA192.24 Million | ILA116.84 Million | ▲ +1.6 pp |
| 2017 | 37.6% | ILA74.57 Million | ILA198.34 Million | ILA123.77 Million | ▲ +1.9 pp |
| 2016 | 35.7% | ILA52.26 Million | ILA146.41 Million | ILA94.15 Million | ▲ +0.6 pp |
| 2015 | 35.1% | ILA34.84 Million | ILA99.17 Million | ILA64.33 Million | ▲ +5.4 pp |
| 2014 | 29.7% | ILA36.97 Million | ILA124.35 Million | ILA87.38 Million | ▲ +0.7 pp |
| 2013 | 29.1% | ILA37.92 Million | ILA130.47 Million | ILA92.56 Million | ▲ +4.3 pp |
| 2012 | 24.7% | ILA125.74 Million | ILA508.18 Million | ILA382.44 Million | ▲ +8.3 pp |
| 2011 | 16.4% | ILA76.42 Million | ILA465.02 Million | ILA388.61 Million | ▼ -1.4 pp |
| 2010 | 17.8% | ILA18.62 Million | ILA104.57 Million | ILA85.94 Million | ▼ -3.5 pp |
| 2009 | 21.3% | ILA20.27 Million | ILA95.07 Million | ILA74.81 Million | ▼ -2.0 pp |
| 2008 | 23.3% | ILA22.25 Million | ILA95.36 Million | ILA73.11 Million | ▼ -13.0 pp |
| 2007 | 36.4% | ILA34.85 Million | ILA95.88 Million | ILA61.03 Million | ▲ +6.3 pp |
| 2006 | 30.0% | ILA23.83 Million | ILA79.38 Million | ILA55.55 Million | — |